Literature DB >> 3278752

Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism.

S A Cannistra1, E Vellenga, P Groshek, A Rambaldi, J D Griffin.   

Abstract

Human colony-stimulating factors (CSF) exert multiple effects on the proliferation, differentiation, and function of myeloid lineage cells. In this study, the effects of three recombinant human CSFs (granulocyte-monocyte CSF [GM-CSF], interleukin 3 [IL-3], and granulocyte CSF [G-CSF]) on antibody-independent monocyte tumoricidal activity were investigated by using WEHI 164 fibrosarcoma cells as monocyte-sensitive targets. None of the CSFs directly induced monocyte cytotoxicity, although both GM-CSF and IL-3 were found to significantly enhance monocyte killing in response to a second stimulatory event (endotoxin). No effect was seen with G-CSF. Antitumor necrosis factor antibody completely abolished CSF-enhanced monocyte cytotoxicity, which suggests that this effect was mediated through increased release of tumor necrosis factor (TNF). As previously shown for GM-CSF, IL-3 was found to induce cytoplasmic accumulation of TNF messenger RNA (mRNA) after 18 hours of exposure. These results suggest that GM-CSF and IL-3 may stimulate monocyte killing indirectly by enhancing expression of TNF mRNA, thereby leading to augmented TNF protein secretion in response to a second activation signal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278752

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Modulation of human monocyte superoxide production by recombinant interleukin-3.

Authors:  V Jendrossek; S Buth; C Stetter; M Gahr
Journal:  Agents Actions       Date:  1992-09

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.

Authors:  Ehab Azab; Kevin Brown Chandler; Yuhei Uda; Ningyuan Sun; Amira Hussein; Raghad Shuwaikan; Veronica Lu; Catherine E Costello; Mark E McComb; Paola Divieti Pajevic
Journal:  FASEB J       Date:  2020-06-18       Impact factor: 5.191

Review 4.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 5.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 6.  Haemopoietic colony stimulating factors for preterm neonates.

Authors:  R Carr; N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

Review 7.  Regulation of colony-stimulating factor production by normal and leukemic human cells.

Authors:  T J Ernst; J D Griffin
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

8.  Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.

Authors:  G Tiegs; J Barsig; B Matiba; S Uhlig; A Wendel
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 9.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

10.  Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.

Authors:  F Herrmann; A Lindemann; W Lange; G Köchling; A Raghavachar; H Schrezenmeier; N Frickhofen; R H Mertelsmann
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.